Clinical Trial Update: Prospective Study With FLOT in Patients With Locally Advanced, Limited Metastatic or Extensive Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction [Phase 2]

View source ↗

Summary

Phase 2 prospective trial evaluating the FLOT regimen in locally advanced, limited metastatic, or extensive metastatic adenocarcinoma of the stomach or esophago…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Esophagogastric Junction
• Gastric Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• DOCETAXEL (DOCETAXEL)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Krankenhaus Nordwest | Conditions: Gastric Cancer, Adenocarcinoma of the Esophagogastric Junction | Phase 2 | Status: COMPLETED